These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Lipid disorders in NIDDM: implications for treatment. Taskinen MR; Smith U J Intern Med; 1998 Nov; 244(5):361-70. PubMed ID: 9845851 [TBL] [Abstract][Full Text] [Related]
12. Primary prevention of coronary heart disease: where do we go from here? Gotto AM Arch Intern Med; 2001 Apr; 161(7):922-4. PubMed ID: 11295953 [No Abstract] [Full Text] [Related]
13. [Overviews of fibrate]. Tada N Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141 [No Abstract] [Full Text] [Related]
18. Residual coronary risk in men aged 50-59 years treated for hypertension and hyperlipidaemia in the population: the PRIME study. Blacher J; Evans A; Arveiler D; Amouyel P; Ferrières J; Bingham A; Yarnell J; Haas B; Montaye M; Ruidavets JB; Ducimetière P; J Hypertens; 2004 Feb; 22(2):415-23. PubMed ID: 15076202 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic management of the dyslipidemic patient]. Agence Française de Sécurité Sanitaire des Produits de Santé Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):70-5. PubMed ID: 11240406 [No Abstract] [Full Text] [Related]
20. Should hyperlipidaemia in dialysis patients be treated? Wheeler DC Nephrol Dial Transplant; 1997 Jan; 12(1):19-21. PubMed ID: 9027766 [No Abstract] [Full Text] [Related] [Next] [New Search]